For example, p53 inhibits GBM cell proliferation by blocking cell cycle progression and promoting apoptosis; however, in PD, increased p53 expression upregulates the expression of α-synuclein and its subsequent aggregation in which promotes disease progression (49, 50). This evidence concerns the gene TP53 and Parkinson disease.